ODDB.org: Open Drug Database

Lunsumio 30 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung -

Swissmedic Key	68314002	Registration Holder	Roche Pharma (Schweiz) AG
Name	Lunsumio 30 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	09.02.2023
		Introduction of Sequence	09.02.2023
ATC-Classification	Mosunetuzumab (L01FX25)	Revision date
WHO	WHO-DDD	Valid until	09.02.2027
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	6981.30
Deductible	k.A.	Consumer price	7470.60
Feedback	FB
GTIN	7680683140021	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

Solutio concentrata: mosunetuzumabum 30 mg, histidinum, acidum aceticum glaciale, methioninum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 30 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose	additional_information
Mosunetuzumabum	30mg / 30ml	Solutio concentrata

BAG: Active Agent	Dose
Mosunetuzumabum	30 mg

Inactive agents
Acidum Aceticum Glaciale
Histidine
Methionine
Polysorbatum 20
Saccharum

Source

Data was imported : 09.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2026	©ywesee GmbH